Home » Nicolas Ploquin, new CEO of Mercurius Health Group
 Nicolas Ploquin, new CEO of Mercurius Health Group

Nicolas Ploquin, new CEO of Mercurius Health Group

Mercurius Health, one of Europe’s leading operators in radiotherapy and nuclear medicine for hospitals and cancer centres, has entered a new era with the appointment of Nicolas Ploquin as the company’s new CEO three months ago.

After his global career at Unilabs and Johnson & Johnson, among other leading healthcare firms, Nicolas Ploquin now joins Mercurius Health with the challenge to drive growth, innovation and excellence in healthcare. With more than 20 years of experience in medical equipment and healthcare management, Mercurius Health’s new CEO is on a mission to lead the company towards innovation, operational efficiency and technological advancements that will ensure it remains at the forefront of cancer treatment, bringing best in class diagnostic and treatment to all patients in Europe.

“I am passionate about improving patient outcomes and advancing partnerships that enable cutting-edge treatments across the industry. My leadership philosophy centres on collaboration, sustainability and continuous improvement, empowering our teams to deliver the highest quality care and services to our clients and patients. The Mercurius team has a unique and extensive knowledge of the industry and the market, and I am excited to be able to contribute to its development. With the aging of the population in Europe and medical innovation allowing personalization of treatment, we have a mission to bring best-in-class diagnostic and therapies to all cancer patients in Europe. I have been a patient myself and this mission resonates and gives me the “fire in the belly” everyday”, says Nicolas Ploquin after taking up his new role.

The group welcomes its new CEO and is confident that with his proven track record in driving growth and a passion for innovation in patient care, he is ready to take Mercurius Health to its next phase.

About Mercurius Health Group

Mercurius Health Group is one of Europe’s leading providers of advanced oncology solutions, specialising in radiotherapy and nuclear medicine for hospitals and cancer centres. We develop, operate and support centres in over 15 locations and are currently present in Germany, Spain, Portugal and the UK, and provide services across Europe.
With more than 35 years of experience, we are a highly specialised team with expertise in a wide range of radiotherapy and nuclear medicine equipment and practices, as well as in the construction and management of oncology facilities. We are focused on strategic partnerships with healthcare institutions to provide cutting-edge treatments for their oncology patients. Our solutions entail the management of the complete project for developing new services or installing new equipment, from design, equipment selection and procurement, including project implementation, operations, and financing.
The Mercurius Health Group operates its own centres such as the WEGE Klinik (formerly Robert Janker Klinik), a renowned oncology hospital in Bonn, Germany, as well as CADPET, a nuclear medicine network in Spain. This allows the clinical, technical and management teams to always be up to date on the latest improvements in real tangible projects.
Mercurius Health has headquarters in Madrid and Lisbon, but also offices in London, Bonn and Malaga.

For further information and interviews:

Laura Terzagui – Marketing & Communications Group Director – laura.terzagui@mercuriushealth.com

Leave a Reply

Your email address will not be published. Required fields are marked *